Read + Share
Amedeo Smart
Independent Medical Education
Hedskog C, Rodriguez L, Roychoudhury P, Huang ML, et al. Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1). J Infect Dis 2023;228:1263-1273.PMID: 37466213
Email
LinkedIn
Facebook
Twitter
Privacy Policy